Kezar Life Sciences, Inc. (KZR)

Kezar Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	38.94	41.75	35.49	40.46	62.88	21.23
Short-Term Investments	51.28	90.5	165.88	236.11	145.47	119.22
Cash & Short-Term Investments	90.22	132.25	201.37	276.56	208.36	140.45
Cash Growth	-39.20%	-34.33%	-27.19%	32.73%	48.35%	79.59%
Other Receivables	-	0.42	2.29	0.77	-	0.77
Receivables	-	0.42	2.29	0.77	-	0.77
Prepaid Expenses	4.29	1.09	1.22	1.12	2.57	2.73
Other Current Assets	-	3.73	2.07	7.27	0.73	0.87
Total Current Assets	94.5	137.49	206.95	285.72	211.65	144.81
Property, Plant & Equipment	3.23	4.78	8.69	13.17	6	6.75
Other Long-Term Assets	-	2.42	5.6	0.67	0.28	0.28
Total Assets	97.73	144.68	221.24	299.57	217.93	151.84
Accounts Payable	0.91	3.65	8.25	2.48	2.03	2.36
Accrued Expenses	3.93	7.94	6.48	5.95	4.99	3.04
Current Portion of Long-Term Debt	5.28	5.22	-	-	-	-
Current Portion of Leases	3.26	3.53	3.01	2.57	1.2	1.04
Total Current Liabilities	13.38	20.33	17.74	11	8.21	6.44
Long-Term Debt	1.37	5.11	10.07	9.83	9.62	-
Long-Term Leases	-	2.33	5.85	8.87	3.22	4.42
Total Liabilities	14.75	27.77	33.67	29.7	21.06	10.86
Common Stock	0.01	0.01	0.01	0.07	0.06	0.05
Additional Paid-In Capital	558.94	551.57	538.46	519.62	377.77	267.09
Retained Earnings	-475.99	-434.5	-350.76	-248.89	-180.65	-126.02
Comprehensive Income & Other	0.01	-0.16	-0.13	-0.92	-0.29	-0.14
Total Common Equity	82.98	116.92	187.57	269.87	196.88	140.98
Shareholders' Equity	82.98	116.92	187.57	269.87	196.88	140.98
Total Liabilities & Equity	97.73	144.68	221.24	299.57	217.93	151.84
Total Debt	9.91	16.18	18.93	21.26	14.04	5.46
Net Cash (Debt)	80.3	116.07	182.44	255.3	194.31	134.98
Net Cash Growth	-38.92%	-36.38%	-28.54%	31.39%	43.95%	87.89%
Net Cash Per Share	10.99	15.92	25.15	37.90	36.83	30.68
Filing Date Shares Outstanding	7.32	7.31	7.28	7.08	5.67	4.81
Total Common Shares Outstanding	7.32	7.3	7.28	6.85	5.63	4.64
Working Capital	81.13	117.16	189.21	274.73	203.44	138.37
Book Value Per Share	11.33	16.01	25.77	39.40	34.99	30.41
Tangible Book Value	82.98	116.92	187.57	269.87	196.88	140.98
Tangible Book Value Per Share	11.33	16.01	25.77	39.40	34.99	30.41
Machinery	-	5.85	5.84	4.67	3.67	2.91
Leasehold Improvements	-	3.49	3.49	3.37	3.27	3.27

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q